FDA approves grape-flavored Delsym
This article was originally published in The Tan Sheet
Executive Summary
FDA approved Adams Respiratory Therapeutics supplemental New Drug Application for a grape-flavored formulation for Delsym on Sept. 28 and the company will begin immediately distributing the cough medicine product, Chester, N.J.-based Adams says. Upon acquiring Delsym from USB in May 2006, the firm said it would pour $15 mil-$20 mil. annually into distribution and promotions (1"The Tan Sheet" May 29, 2006, p. 5)...